Gold miners gain as bullion rises more than 1% on risk-off mood, dollar pause
ReutersNov 5, 2025 10:12 AM
U.S.-listed shares of gold miners gain premarket, tracking a rise in prices of the bullion GOL/
Spot gold XAU= up 1.3% at $3,981.27/ounce
Prices rise on a slight U.S. dollar pullback and wider risk-off sentiment driving demand
Top miners Newmont NEM.N and Barrick Mining B.N both rise ~1% each
South African miners Sibanye Stillwater SBSW.N and Gold Fields GFI.N up 3.1% and 4.4%, respectively
Canadian miners Kinross Gold K.TO, KGC.N and Agnico Eagle Mines AEM.TO, AEM.N up 1.8% and 1.3%, respectively
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemicTradingKey
3 hours ago
IonQ Stock Price Skyrockets 300% in a Year, But Recently Drops 30%—Is IonQ Still a Buy?
Is IonQ worth buying? With a recent decline of nearly 30% over the past month, is now the time to buy? How much further could IonQ's stock rise?TradingKey
4 hours ago
The Tariff Refund Drama Begins: Five Major Impacts If Trump Loses the Supreme Court Case
TradingKey - A landmark legal battle with clear undertones of “small business vs. government” will unfold at the U.S. Supreme Court on November 5, a case President Donald Trump has called “the most important in American history.” The ruling will directly determine the legality of Trump’s signatureTradingKey
23 hours ago
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.TradingKey
Tue, Nov 4
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.TradingKey
Tue, Nov 4
